{
  "id": "5fe31312a43ad31278000042",
  "type": "factoid",
  "question": "Which is the master oncogenic transcription factor in T-cell acute lymphoblastic leukemia?",
  "ideal_answer": "The oncogenic transcription factor TAL1/SCL induces an aberrant transcriptional program in T-Cell Acute lymphoblastic Leukemia (T-ALL) cells.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/28028313",
    "http://www.ncbi.nlm.nih.gov/pubmed/27550837",
    "http://www.ncbi.nlm.nih.gov/pubmed/32633635",
    "http://www.ncbi.nlm.nih.gov/pubmed/28652130",
    "http://www.ncbi.nlm.nih.gov/pubmed/29326336",
    "http://www.ncbi.nlm.nih.gov/pubmed/9507011",
    "http://www.ncbi.nlm.nih.gov/pubmed/14604958",
    "http://www.ncbi.nlm.nih.gov/pubmed/30145780",
    "http://www.ncbi.nlm.nih.gov/pubmed/22897851",
    "http://www.ncbi.nlm.nih.gov/pubmed/28179281",
    "http://www.ncbi.nlm.nih.gov/pubmed/23263491"
  ],
  "snippets": [
    {
      "text": "We identify CNOT3 as a tumor suppressor mutated in 7 of 89 (7.9%) adult T-ALLs, and its knockdown causes tumors in a sensitized Drosophila melanogaster model. In addition, we identify mutations affecting the ribosomal proteins RPL5 and RPL10 in 12 of 122 (9.8%) pediatric T-ALLs, with recurrent alterations of Arg98 in RPL10.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23263491",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29326336",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The oncogenic transcription factor TAL1/SCL induces an aberrant transcriptional program in T-cell acute lymphoblastic leukemia (T-ALL) cells.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29326336",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Our results indicate that ARID5B reinforces the oncogenic transcriptional program by positively regulating the TAL1-induced regulatory circuit and MYC in T-ALL, thereby contributing to T-cell leukemogenesis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29326336",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28652130",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "BACKGROUND: T-cell acute lymphoblastic leukemia is a hematologic malignancy characterized by T-cell proliferation, and in many cases, the ectopic expression of the oncogenic transcription factor T-cell acute lymphocytic leukemia protein 1 (TAL1).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32633635",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "MiR-7 Functions as a Tumor Suppressor by Targeting the Oncogenes TAL1 in T-Cell Acute Lymphoblastic Leukemia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32633635",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Aberrant expression of transcription factor oncogenes such as HOX11, HOX11L2, TAL1/SCL, LYL1, LMO1, and LMO2 can be detected in lymphoblasts from up to 80% of patients with acute T-cell lymphoblastic leukemia (T-ALL).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/14604958",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The transcription factor TAL1/SCL is one of the most prevalent oncogenes in T-cell acute lymphoblastic leukemia (T-ALL), a malignant disorder resulting from leukemic transformation of thymus T-cell precursors.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28028313",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28652130",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The transcription factor TAL1/SCL is one of the most prevalent oncogenes in T-cell acute lymphoblastic leukemia (T-ALL), a malignant disorder resulting from leukemic transformation of thymus T-cell precursors. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28028313",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The oncogenic transcription factor TAL1/SCL is aberrantly expressed in over 40% of cases of human T\u00a0cell acute lymphoblastic leukemia (T-ALL), emphasizing its importance in the molecular pathogenesis of T-ALL. H",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22897851",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The Tal1 oncogene is a class II basic helix-loop-helix (bHLH) transcription factor, overexpressed in as much as 60% of T cell acute lymphoblastic leukemia cases. Li",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9507011",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "SCL/TAL1 (stem cell leukemia/T-cell acute lymphoblastic leukemia [T-ALL] 1) is an essential transcription factor in normal and malignant hematopoiesis. It",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28179281",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Previous results indicated that miR-146b-5p is downregulated by TAL1, a transcription factor critical for early hematopoiesis that is frequently overexpressed in T-cell acute lymphoblastic leukemia (T-ALL) where it has an oncogenic role. H",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27550837",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In this review, we focus on the oncogenic transcription factor TAL1 and the tumor-suppressor E-proteins and discuss the malignant cell state, the transcriptional circuit, and the consequence of molecular abnormalities in T-ALL.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28652130",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The oncogenic transcription factor TAL1/SCL is aberrantly expressed in over 40% of cases of human T\u00a0cell acute lymphoblastic leukemia (T-ALL), emphasizing its importance in the molecular pathogenesis of T-ALL.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22897851",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Oncogenic transcriptional program driven by TAL1 in T-cell acute lymphoblastic leukemia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30145780",
      "beginSection": "title",
      "endSection": "title"
    }
  ],
  "concepts": [],
  "exact_answer": "TAL1"
}